MCMariya Campbell

Mariya Campbell

*This is an algorithmically generated author record based on publicly available information.

Mariya Campbell has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda K. Lyons

    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    3 shared publications
  • Angela Coulliette-Salmond

    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    3 shared publications
  • Christine Ganim

    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    3 shared publications
  • Magdalena Medrzycki

    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    3 shared publications
  • Maroya Spalding Walters

    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    3 shared publications
  • Adam C. Retchless

    Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA

    2 shared publications

Latest Publications

  • Open Access

    Insights from wastewater surveillance of SARS-CoV-2 in skilled nursing facilities: comparing virus concentration methods for wastewater and correlating wastewater virus concentrations with clinical infections, Georgia, USA, 2022

    by Florence Whitehill, Amanda K. Lyons, Bethelhem Abera, Colin Adler, Maria Burgos-Garay, Mariya Campbell, Ariel J. Santiago, Christine Ganim, Jamari Moore, Yimu Cahela, et al.

    A pictographic representation of the text abstract showing wastewater and epidemiologic data flow and data integration. To understand the utility of healthcare facility-level wastewater surveillance (WWS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is important to correlate wastewater SARS-CoV-2 RNA detection with the number of clinical infections. WWS for SARS-CoV-2 was performed at three skilled nursing facilities (SNFs) over 25 weeks. Electronegative membrane filtration (enMF) and Nanotrap® Magnetic Virus Particles (NP) virus concentration methods were compared. Extracts were tested by droplet digital polymerase chain reaction. Spearman's correlations (ρ) between wastewater virus RNA concentrations and infection counts were calculated. From split wastewater samples, enMF recovered higher SARS-CoV-2 RNA concentrations than NP. Combining data from all facilities, the median concentrations were 53.0 versus 38.6 gc/100 mL for enMF and NP, respectively (p = 0.001). Using enMF, correlations were moderate to strong at SNF A (ρ ranged 0.67–0.86, all p-values <0.001). Weak to moderate correlations may reflect the sampled manhole not representing the entire facility (SNF B, ρ ranged 0.47–0.72, p-values ranged <0.001–0.12) and longitudinal data gaps from summer heat and equipment maintenance (SNF C, ρ ranged 0.14–0.59, p-values ranged<0.01 to 0.52). WWS can be a valuable tool for tracking dynamics of SARS-CoV-2 infections in healthcare facilities.

  • Open Access

    Healthcare wastewater surveillance: methodological considerations for sampling, feasibility, and implementation

    by Angela Coulliette-Salmond, Florence Whitehill, Amanda K. Lyons, Bethelhem Abera, Colin Adler, Maroya Spalding Walters, Magdalena Medrzycki, Christine Ganim, Mariya Campbell, Michael Y. Lin, et al.

    Wastewater surveillance (WWS) at healthcare facilities is a nascent field with knowledge gaps in the feasibility of conducting such surveillance at this specialized facility type, and for how to best implement and interpret wastewater (WW) data. WWS was piloted at skilled nursing facilities, including conducting tracer studies, optimization of a low-flow strainer for autosampler WW collection, and preliminary testing of a WW access survey. An expanded WW access survey with collaboration from additional partners was distributed to 16 post-acute/long-term care facilities. The lessons learned obtained through the pilot ‘use cases’ demonstrated minimal clogging and consistent collection of WW using a low-flow strainer (±0.36 L) and tracer studies highlighted the importance to confirm facility effluent source with an average visual dye detection between 1.5 and 2.5 min from the toilet flush. The expanded WW access survey assessed the feasibility of WWS regarding physical onsite manhole access, safety aspects, effluent flow, and other factors, where 75% (12 of 16) of surveyed facilities demonstrated feasibility. Healthcare facility-level WWS includes specialized methodological approaches prior to implementation to achieve the intended public health impact. These considerations support the continued overall goal of detecting emerging biological public health threats at healthcare facilities using WWS.


  • Open Access

    Skilled nursing facility wastewater surveillance: a SARS-CoV-2 and antimicrobial resistance detection pilot study

    by Ariel Jose Santiago, Maria Burgos Garay, Mariya Campbell, Yimu Cahela, Rodney Donlan, Paige Gable, Christine Ganim Kyros, Lauren Franco, Leila Kartforosh, Susanna Lenz, et al.

    The purpose of this study was to determine the feasibility of facility-level wastewater surveillance in the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in skilled nursing facility (SNF) wastewater using three concentration methods, as well as a proof-of-concept for antimicrobial resistance (AR) genes/organisms detection. Wastewater effluent samples were collected from an SNF over an 8-week period. Wastewater was concentrated using electronegative membrane filtration (enMF), polyethylene glycol precipitation, and Nanotrap® magnetic virus particles (NP). Quantification of the genome copy concentration from SARS-CoV-2 and bovine respiratory syncytial virus (BRSV), a SARS-CoV-2 surrogate spiked into all samples, was performed with droplet digital polymerase chain reaction (ddPCR). Wastewater sample aliquots were also enriched in microbiological culture media and screened for organisms with AR phenotypes on selective and differential agars. Multiplex real-time PCR was used to detect a broad array of carbapenem resistance genes. SARS-CoV-2 was detected and quantified from a single enMF-concentrated wastewater sample. The highest concentration of BRSV came from enMF-concentrated samples. Klebsiella, Enterobacter, Citrobacter, and Escherichia coli exhibiting AR phenotypes were successfully detected using culture-dependent approaches. Culture-independent, multiplex PCR indicated that blaKPC was the main carbapenemase gene detected in wastewater samples. Facility-level wastewater surveillance could be a useful strategy for SNFs.